首页 > 期刊杂志 > 正文

B-Lymphoblastic Leukemia in Patients With Chronic Lymphocytic Leukemia: A Report of Four Cases.

B-淋巴母细胞性白血病合并慢性淋巴细胞白血病:附四例报告

Chakhachiro Z,Yin CC,Abruzzo LV,Aladily TN,Barron LL,Banks HE,Thomas DA,Keating M,Medeiros LJ,Huh YO

Abstract

B-lymphoblastic leukemia (B-LBL) arising in patients with chronic lymphocytic leukemia (CLL) is exceedingly rare and poorly characterized.
We describe four patients with CLL and concurrent or subsequent B-LBL diagnosed by morphologic, immunophenotypic, cytogenetic, and molecular analysis and reviewed the literature.
In three patients, B-LBL followed CLL by 5 to 15 years, and in one patient, B-LBL was diagnosed simultaneously with CLL. In all cases, the CLL had a typical immunophenotype, and the B-LBL blasts showed an immature B-cell immunophenotype with expression of CD10, CD19, and TdT and absence of surface immunoglobulin. In two patients, B-LBL blasts harbored t(9;22)(q34;q11.2)/BCR-ABL1. We sequenced the IGHV genes in both CLL and B-LBL in two patients and showed that IGHV usage differed.
Our data suggest that at least some cases of B-LBL arising in patients with CLL are independent, secondary neoplasms rather than a manifestation of histologic transformation.

摘要

发生于慢性淋巴细胞白血病(CLL)的B淋巴母细胞白血病(B-LBL)是极为罕见的,形态特征也认识不足。

我们描述了四例CLL患者,同时或随后发生了B-LBL,利用形态学、免疫表型、细胞遗传学和分子生物学检测综合诊断并进行了文献复习。

在3例患者中, CLL后5年-15年发生B-LBL,1例患者同时诊断患有CLL和B-LBL。所有病例,CLL都有典型的免疫表型,B-LBL母细胞显示不成熟B细胞免疫表型,表达CD10、CD19和TdT,且表面免疫球蛋白表达缺乏。在2例患者中,B-LBL母细胞有t(9; 22)(q34;q11.2)/ BCR-ABL1。对两例CLL和B-LBL均进行了IgH V基因测序,结果表明IgH V 不同。

我们研究数据表明,至少某些起源于CLL的B-LBL是独立的、继发性肿瘤而不是病理组织学特征转化的表现。

full text

我要评论

0条评论